How far are we from the clinical use of placental-derived mesenchymal stem cells?

Alessandra Fierabracci, Lorenza Lazzari, Maurizio Muraca, Ornella Parolini

Risultato della ricerca: Contributo in rivistaArticolo in rivista

19 Citazioni (Scopus)


In recent years, multiple studies have investigated the biology and clinical applications of mesenchymal stem cells (MSCs), trying to define their markers, and elucidate their effects in animal models. MSCs are available from different tissues, and the use of placental-derived MSCs (PMSCs) for treating a variety of disorders is on the forefront. Herein, we discuss the most recent findings regarding the standardization of their isolation procedure and phenotype, along with advantages and limitations of their use. We also discuss the safety of the placental cell products, including the issue of senescence and mutagenesis of PMSCs, and efficacy from preclinical studies.
Lingua originaleEnglish
pagine (da-a)613-617
Numero di pagine5
RivistaExpert Opinion on Biological Therapy
Stato di pubblicazionePubblicato - 2015


  • Animals
  • Cell Differentiation
  • Female
  • Mesenchymal Stem Cell Transplantation
  • Mesenchymal Stromal Cells
  • Placenta
  • Pregnancy
  • isolation procedure
  • phenotype
  • placenta
  • placental mesenchymal stem cells
  • safety
  • stability
  • therapeutic application
  • tumorigenesis


Entra nei temi di ricerca di 'How far are we from the clinical use of placental-derived mesenchymal stem cells?'. Insieme formano una fingerprint unica.

Cita questo